Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000060

General Counsel sold 733 shares at $69.69 ($51,083)

From the SEC's structured data for this filing

Trades in this filing

Quinlan Paul T · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Sale : show line 1 in the form −733 $69.69 $51,083 31,034 D
Open-market sales · 733 sh · avg $69.69 · $51,083
Loading xslF345X06/form4.xml…